cbdMD, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$12M
↑+2.1% +$239Kvs FY2024
Total Liabilities
$3M
↓-69.7% -$6Mvs FY2024
Equity
$9M
↑+405.6% +$7Mvs FY2024
Cash
$3M
↑+72.0% +$1Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $12M | $12M |
| Current Assets | $8M | $6M |
| Cash | $3M | $2M |
| ST Investments | $0 | $0 |
| Receivables | $745K | $631K |
| Inventory | $3M | $2M |
| Other Current | $888K | $1M |
| Non-Current Assets | $4M | $5M |
| PPE | $388K | $512K |
| Goodwill | $0 | $0 |
| Intangibles | $2M | $3M |
| Investments | $0 | $0 |
| Other Non-Current | $1M | $2M |
| Total Liab+Eq | $12M | $12M |
| Current Liab. | $3M | $9M |
| Accounts Payable | $881K | $1M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $489K | $527K |
| Other CL | $1M | $7M |
| Non-Current Liab. | $0 | $592K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $592K |
| Equity | $9M | $2M |
| Retained Earnings | $180M | $183M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · YCBD · Comparing FY2025 vs FY2024